AXA Framlington Biotech Fund - R Accumulation (0P0000XMRD)

ロンドン

ポートフォリオに追加/削除するポートフォリオに加える

5.177 +0.040 +0.82%

03/05 - 終了. GBP 通貨 ( 免責条項 )

タイプ: 投資信託

市場: イギリス

発行者: AXA Equitable

ISIN: GB00B784NS11

資産クラス: 株式

モーニングスターの評価:
総資産: 343.19M

概要
プロフィール
過去のデータ
保有資産

0P0000XMRD 概要

このページではAXA Framlington Biotech Fund - R Accumulationの基本的な企業情報をご覧になれます。 0P0000XMRD の主要な経営陣、総資産、投資戦略、連絡先情報など。

カテゴリー

Sector Equity Biotechnology

総資産

343.19M

費用

0.83%

開始日

2012年04月16日

連絡先

住所 100, Esplanade du Général de Gaulle
Paris, 92932
France

電話 +33 1 44 45 70 00

ファクス Paris

ウェブ www.axa-im-international.com

役員トップ

名前	タイトル	以来	まで
Cinney Zhang	-	2023	now
Linden Thomson	-	2012	now
Peter Hughes	Portfolio Manager	2001	2023
伝記	Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News.
Dani Saurymper	-	2015	2020
伝記	Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare.
Gemma Game	-	2011	2015
Deane Donnigan	clinical Specialist	2010	2011
伝記	Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen.
Andy Smith	Portfolio manager	2009	2010
伝記	Andy joined AXA Framlington in April 2008 as Portfolio Manager within the healthcare team with specific responsibility for the AXA Framlington Biotech Fund. Previously, he spent three years at SV Life Sciences where he was responsible for managing a global biotechnology investment fund. From 2004 to 2005 he worked at Schroders as Director and Fund Manager, Global Equities. Between 2002 and 2004 he worked within the Asset Management division of the 3i Group as Investment Manager and then Director.
Deane Donnigan	clinical Specialist	2007	2009
伝記	Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen.
Gareth Powell	Portfolio Manager	2004	2007
伝記	Gareth Powell joined Polar Capital in 2007 to establish the healthcare investment team. He is joint manager of the Healthcare Opportunities Fund. He joined Framlington in 1999, later becoming a portfolio manager on the Framlington Health Fund. In 2002, Gareth helped launch the Framlington Biotech Fund, which he managed until his departure. Gareth studied biochemistry at Oxford, during which time he worked at Yamanouchi, a leading Japanese pharmaceutical company (later to become Astellas), as well as various academic laboratories including the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and Oxford Business School. He is a CFA charterholder.
Antony Milford	-	2001	2007

他のユーザーと交流したり、あなたの見通しを他の人と共有したり、筆者に質問するにはコメントを使うことをお勧めします。

我々みんなが高いレベルの議論を維持するために以下の事を心に留めてください。

会話を豊かにしようとする。
集中し、主題から外れない。論じられたトピックに関することだけを書きこむ。
敬意を示す。否定的な意見も、前向きに相手を思いやった表現に言い換える。
句読点や大文字小文字などは、標準のライティングスタイルを使う。
注意:スパムやコメント内の宣伝のメッセージやリンクは省かれます。
著者や他のユーザーを冒涜、中傷する個人的攻撃は禁じます。
日本語でのコメントのみ許されています。

スパムや乱用の加害者は、サイトから削除され、Investing.comの裁量により今後の登録が禁じます。

私はInvesting.comのコメントガイドラインを読み、記述されている条件に同意します。

同意することとします

0P0000XMRD 口コミ

AXA Framlington Biotech Fund - R Accumulationについての考えを書いてください

本当にこのチャートを削除しますか

削除キャンセル

投稿する

:にも投稿する

添付のチャートを新しいチャートと置き換えますか？

置き換えるキャンセル

1000

コメントガイドライン

良くないユーザーレポートのために、現在コメントすることができません。このステータスは当社モデレーターが再確認します。

１分待ってから再度コメントしてください。

コメントをありがとうございます。担当者が承認するまでコメントは掲示されません。掲示されるまで少しだけお時間がかかります。

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">たった今</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>シェアする</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>この投稿をフォローする            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>この投稿のフォローをやめる            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			保存する		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>保存されました。<a href="/members-admin/saved-items" target="_blank">保存したアイテム</a>を参照してください。</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>このコメントはすでに <a href="/members-admin/saved-items" target="_blank">保存したアイテム</a>に保存されています</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>著者の返事</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d11-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">返事をする</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="同意します"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="同意しません"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">レポート</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">たった今</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>著者の返事</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>シェアする</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d11-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d11-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">返事をする</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="同意します"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="同意しません"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

本当にこのチャートを削除しますか

削除キャンセル

投稿する

添付のチャートを新しいチャートと置き換えますか？

置き換えるキャンセル

1000

コメントガイドライン

良くないユーザーレポートのために、現在コメントすることができません。このステータスは当社モデレーターが再確認します。

１分待ってから再度コメントしてください。

このコメントについて下記のように感じます

スパム

不快

ありがとうございます!

報告は、確認のため管理担当に送られました

さらに分類

1日1週1ヵ月６ヵ月1年5年最大

日経平均株価	38,236.07	-37.98	-0.10%
日経225先物 (F)	38,357.5	+395.0	+1.04%
韓国総合株価指数	2,676.89	-6.76	-0.25%
NYダウ	38,675.68	+450.02	+1.18%
独DAX	17,993.69	+97.19	+0.54%
S&P/ASX 200	7,629.00	+42.00	+0.55%
米ドル指数	104.950	-0.228	-0.22%

金	2,309.70	+0.10	+0.00%
原油 WTI	78.01	-0.94	-1.19%
銀	26.777	-0.052	-0.19%
米国綿花2番	77.96	+2.34	+3.09%
排出権	71.84	-0.67	-0.92%
米国シカゴコーン	460.12	+0.12	+0.03%
米国コーヒー	200.55	-5.55	-2.69%

ドル/円	152.93	-0.69	-0.45%
ドル/ウォン	1,355.92	-10.83	-0.79%
ユーロ/ドル	1.0764	+0.0040	+0.37%
ユーロ/円	164.63	-0.17	-0.10%
トルコリラ/円	4.7315	-0.0165	-0.35%
豪ドル/円	101.12	+0.25	+0.25%
ポンド/円	191.92	-0.66	-0.34%

大塚ホールディングス	6,382.0	-179.0	-2.73%
SoftBank Group Corp.	7,793.0	+4.0	+0.05%
トヨタ自動車	3,581.0	-24.0	-0.67%
三菱UFJフィナンシャル・グループ	1,554.0	-9.5	-0.61%
ブイ・テクノロジー	2,539.0	-23.0	-0.90%
東芝	4,590.0	0.0	0.00%
みずほフィナンシャルグループ	3,008.0	-10.0	-0.33%

閲覧履歴

	名前	価格	前日比	変動%
	AXA Framlington B.	5.177	+0.040	+0.82%